Literature DB >> 18756385

Delayed ocular, pulmonary, and cutaneous complications of mustards in patients in the city of Sardasht, Iran.

Mohammad Ghassemi-Broumand1, Jafar Aslani, Seyed-Naser Emadi.   

Abstract

The purpose of our study was to evaluate the late ocular, pulmonary, and cutaneous complications of mustards, 19 years after exposure in 600 patients of the city of Sardasht, Iran. In this case study, we evaluated 600 warfare patients aged 19 to 80 years whose mustard gas injury dated back to 19 years before evaluation in Sardasht. Our results showed that 5.2% of our cases were aged 19-20 years, 18.5% were aged 21-30 years, 31.7% were aged 31-40 years, 23.5% were aged 41-50 years, 12.2% were aged 51-60 years, 5.5% were aged 61-70 years, and 3.4% were aged 71-80 years. There were 50.3% male patients in our study, and 83.2% of the patients were married. Primary ocular manifestations were present in 96.2% of the cases, respiratory manifestations in 80.7%, and cutaneous manifestations in 83.8%, with a hospitalization rate of 64.7%. Ophthalmic, respiratory, and dermal medications were administered in 72.8%, 66.7%, and 61.8% of cases, respectively. The degree of ocular complications was mild in 36.7% and moderate in 1%. Respiratory complications were mild in 45% and moderate in 0.8%. Cutaneous complications were mild in 31.3% and moderate in 0.2.%. Late mild respiratory complications were significantly more frequent than ocular and cutaneous complications. In conclusion, late mild pulmonary complications were more frequent than mild ocular and cutaneous complications; however, moderate ocular complications were more frequent than moderate pulmonary and cutaneous complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756385     DOI: 10.1080/15569520802327807

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  7 in total

1.  Pirfenidone; can it be a new horizon for the treatment of pulmonary fibrosis in mustard gas-intoxicated patients?

Authors:  Nasim Zamani
Journal:  Daru       Date:  2013-02-18       Impact factor: 3.117

2.  Impact of psychological problems in chemical warfare survivors with severe ophthalmologic complication, a cross sectional study.

Authors:  Gholamhosein Ghaedi; Hassan Ghasemi; Batool Mousavi; Mohammad Reza Soroush; Parvin Rahnama; Farhad Jafari; Siamak Afshin-Majd; Maryam Sadeghi Naeeni; Mohammad Mehdi Naghizadeh
Journal:  Health Qual Life Outcomes       Date:  2012-04-12       Impact factor: 3.186

3.  Reflux esophagitis in war-related sulfur mustard lung disease.

Authors:  Nader Roushan; Fateme Zali; Hamidreza Abtahi; Mehrnaz Asadi; Reza Taslimi; Najme Aletaha
Journal:  Med J Islam Repub Iran       Date:  2014-05-07

4.  Efficacy of omeprazole on cough, pulmonary function and quality of life of patients with sulfur mustard lung injury: A placebo-control, cross-over clinical trial study.

Authors:  Mohammad Hossein Emami; Mohammad Talaei; Yunes Panahi; Amin Saburi; Mostafa Ghanei
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

5.  Sulfur Mustard-induced Changes in Blood Urea Nitrogen, Uric Acid and Creatinine Levels of Civilian Victims, and Their Correlation with Spirometric Values.

Authors:  Ensieh Sadat Mirsharif; Fatemeh Heidary; Mohammad Reza Vaez Mahdavi; Reza Gharebaghi; Shahriar Pourfarzam; Tooba Ghazanfari
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

6.  A review on delayed toxic effects of sulfur mustard in Iranian veterans.

Authors:  Seyed Mansour Razavi; Payman Salamati; Masoud Saghafinia; Mohammad Abdollahi
Journal:  Daru       Date:  2012-10-09       Impact factor: 3.117

Review 7.  Delayed Complications and Long-term Management of Sulfur Mustard Poisoning: Recent Advances by Iranian Researchers (Part I of II).

Authors:  Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Iran J Med Sci       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.